Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.

Rheumatology (Oxford, England)

Volumn 50, Issue 11, 2011, Pages 1944-1954

  Kozera, Lukasz ^a   Andrews, Jacqueline ^b   Morgan, Ann W ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; COMORBIDITY; EPIDEMIOLOGY; HUMAN; INFLAMMATION; METABOLISM; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; UNITED KINGDOM;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HUMANS; INFLAMMATION; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84555195202     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker232     Document Type: Review

References (0)